Results 251 to 260 of about 271,655 (296)
Some of the next articles are maybe not open access.
European Journal of Cancer, 1998
To review the etiology, epidemiology, classification, diagnosis, staging, prognosis, treatment, and nursing implications of non-Hodgkin's lymphoma.Research studies, review articles, and book chapters pertaining to non-Hodgkin's lymphoma.Non-Hodgkins's lymphomas are a heterogeneous group of lympho-proliferative disorders, increasing in frequency, for ...
B A, Bilodeau, K L, Fessele
openaire +4 more sources
To review the etiology, epidemiology, classification, diagnosis, staging, prognosis, treatment, and nursing implications of non-Hodgkin's lymphoma.Research studies, review articles, and book chapters pertaining to non-Hodgkin's lymphoma.Non-Hodgkins's lymphomas are a heterogeneous group of lympho-proliferative disorders, increasing in frequency, for ...
B A, Bilodeau, K L, Fessele
openaire +4 more sources
Critical Reviews in Oncogenesis, 2013
Anemia is a frequent finding of Hodgkin's lymphoma (HL) diagnosis. It is usually mild, with hemoglobin levels between 10 and 12 g/dl; it is rarely (
Hohaus, S +4 more
openaire +4 more sources
Anemia is a frequent finding of Hodgkin's lymphoma (HL) diagnosis. It is usually mild, with hemoglobin levels between 10 and 12 g/dl; it is rarely (
Hohaus, S +4 more
openaire +4 more sources
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Current Hematologic Malignancy Reports, 2018The ligation of PD-1 with PD-L1 activates a critical immune checkpoint leading to T cell dysfunction, exhaustion, and tolerance. Anti-PD-1 or anti-PD-L1 monoclonal antibodies can reverse the immune checkpoint, releasing the brake on T cell responses.
Bei, Hu, Ryan, Jacobs, Nilanjan, Ghosh
openaire +2 more sources
The Lymphomas: Hodgkin's Disease and Non-Hodgkin's Lymphomas
American Pharmacy, 1991This review presents an overview of a heterogeneous group of disorders that fall under the general heading of lymphomas. Many specific subtypes and presentations exist; their presentations, treatments, and prognoses vary greatly. Patients with lymphomas are generally treated with external beam radiation therapy, chemotherapy, or a combination of these ...
openaire +2 more sources
Hodgkin's and Non-Hodgkin's Lymphomas
Radiologic Clinics of North America, 2007The diagnosis and management of lymphoma have undergone significant changes in the past 20 years. For example, new immunophenotypic and molecular methods have replaced traditional histology-based classification schemes for lymphoma. Fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) has evolved into a potent staging tool and prognostic ...
openaire +2 more sources
Cancer, 1995
Significant advances in the understanding of non-Hodgkin's lymphoma (NHL) have occurred in the past two decades, resulting in changes in terminology and classification practices, which may affect the analysis of the Surveillance, Epidemiology, and End Results (SEER) data.The incidence rates for each subgroup of NHL in the Working Formulation were ...
T C, Greiner, L J, Medeiros, E S, Jaffe
openaire +2 more sources
Significant advances in the understanding of non-Hodgkin's lymphoma (NHL) have occurred in the past two decades, resulting in changes in terminology and classification practices, which may affect the analysis of the Surveillance, Epidemiology, and End Results (SEER) data.The incidence rates for each subgroup of NHL in the Working Formulation were ...
T C, Greiner, L J, Medeiros, E S, Jaffe
openaire +2 more sources
Hodgkin Lymphoma and Non-Hodgkin Lymphoma
2021Hematopoietic cell transplantation (HCT) is a key treatment modality in the management of advanced Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Autologous HCT (autoHCT) can be curative for relapsed or refractory HL and diffuse large B-cell lymphoma.
openaire +1 more source
Hodgkin's Lymphoma in Otorhinolaryngology
Acta Otorrinolaringologica (English Edition), 2011To evaluate the implication of Hodgkin's lymphoma (HL) in Otorhinolaryngology.A longitudinal retrospective study on patients with HL diagnosed, treated and followed-up in our Centre from 1996 to 2010.From 413 individuals having lymphoma, 120 were labelled as HL (29%).
Francisco Javier, García-Callejo +5 more
openaire +2 more sources
Hodgkin Lymphoma and Non-Hodgkin Lymphoma
2005Lymphomas account for 10% to 15% of malignancies in pediatric patients. The most common subtypes are Hodgkin lymphoma and non-Hodgkin lymphoma. The prognosis of both forms of lymphoma has improved significantly in the past 30 years. They are now the most “curable” forms of pediatric cancer.
Ka Wah Chan +3 more
openaire +1 more source
Lymphomagenesis in Hodgkin lymphoma
Seminars in Cancer Biology, 2015Hodgkin lymphoma (HL) accounts for approximately 0.6% of all new cancer cases, 10% of all lymphomas in the USA, leading to an approximate 9000 new cases per year. It is very unique in that the neoplastic Hodgkin and Reed-Sternberg (HRS) cells of classical HL account for only 1% of the tumor tissue in most cases, with various inflammatory cells ...
Eri, Matsuki, Anas, Younes
openaire +2 more sources